About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
OCULAR THERAPEUTIX, INC (OCUL): Insider Trades and Fund Holdings
In the past 12 months, OCULAR THERAPEUTIX, INC insiders reported 0 open-market purchases worth $0 and 8 sales worth $568K; 7 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144) and fund moves in the past year, newest first.
- Oct 16, 2026NewsCompany reported: Executive or director change
- Oct 8, 2026Insider saleGeneral Counsel Todd Anderman sold $87,363 under a 10b5-1 plan
- Oct 8, 2026Planned saleTODD ANDERMAN (officer) filed notice to sell about $87,315 around Oct 8, 2026
- Oct 2, 2026Insider saleChief Scientific Officer Jeffrey S. Heier sold $76,626 under a 10b5-1 plan
- Oct 2, 2026Insider saleChief Development Officer Peter Kaiser sold $70,430 under a 10b5-1 plan
- Oct 2, 2026Planned saleJEFFREY S. HEIER (officer) filed notice to sell about $76,639 around Oct 2, 2026
- Oct 2, 2026Planned salePETER KAZUO KAISER (officer) filed notice to sell about $70,459 around Oct 2, 2026
- Aug 31, 2026Insider saleCOO Donald Notman sold $11,254
- Aug 31, 2026Planned saleDONALD D NOTMAN JR. (officer) filed notice to sell about $11,252 around Aug 31, 2026
- Aug 24, 2026Insider saleSee Remarks Pravin Dugel sold $233,160 under a 10b5-1 plan
- Aug 24, 2026Insider saleChief Scientific Officer Jeffrey S. Heier sold $35,531 under a 10b5-1 plan
- Aug 24, 2026Insider saleChief Development Officer Peter Kaiser sold $32,687 under a 10b5-1 plan
- Aug 24, 2026Insider saleChief Strategy Officer Sanjay Nayak sold $20,450 under a 10b5-1 plan
- Aug 24, 2026Planned salePRAVIN DUGEL (officer) filed notice to sell about $233,186 around Aug 24, 2026
- Aug 24, 2026Planned saleJEFFREY S. HEIER (officer) filed notice to sell about $35,532 around Aug 24, 2026
- Aug 24, 2026Planned salePETER KAZUO KAISER (officer) filed notice to sell about $32,702 around Aug 24, 2026
- Aug 24, 2026Planned saleSANJAY NAYAK (officer) filed notice to sell about $20,453 around Aug 24, 2026
- Jun 30, 2026FundRenaissance Technologies cut 67% in Q2 2026 (13F filed Aug 13, 2026)
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 13, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 13 | Todd AndermanGeneral Counsel | ▼ SELL10b5-1 | $87K |
| Oct 6 | Jeffrey S. HeierChief Scientific Officer | ▼ SELL10b5-1 | $77K |
| Oct 6 | Peter KaiserChief Development Officer | ▼ SELL10b5-1 | $70K |
| Sep 2 | Donald NotmanCOO | ▼ SELL | $11K |
| Aug 26 | Pravin DugelSee Remarks | ▼ SELL10b5-1 | $233K |
| Aug 26 | Jeffrey S. HeierChief Scientific Officer | ▼ SELL10b5-1 | $36K |
| Aug 26 | Peter KaiserChief Development Officer | ▼ SELL10b5-1 | $33K |
| Aug 26 | Sanjay NayakChief Strategy Officer | ▼ SELL10b5-1 | $20K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Todd Anderman | General Counsel | 0 | $0 | 1 | $87K |
| Jeffrey S. Heier | Chief Scientific Officer | 0 | $0 | 2 | $112K |
| Peter Kaiser | Chief Development Officer | 0 | $0 | 2 | $103K |
| Donald Notman | COO | 0 | $0 | 1 | $11K |
| Pravin Dugel | See Remarks | 0 | $0 | 1 | $233K |
| Sanjay Nayak | Chief Strategy Officer | 0 | $0 | 1 | $20K |
Tracked funds that report OCUL
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 378,754 | $3.72M | ▼ −67.0% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →